14-45136300-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020937.4(FANCM):c.269C>T(p.Pro90Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000387 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020937.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000290 AC: 73AN: 251496Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135922
GnomAD4 exome AF: 0.000397 AC: 581AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.000399 AC XY: 290AN XY: 727248
GnomAD4 genome AF: 0.000289 AC: 44AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with ovarian or other cancer as well as in unaffected controls (PMID: 28678401, 28881617); This variant is associated with the following publications: (PMID: 28678401, 27713038, 28881617, 34326862) -
The FANCM c.269C>T (p.Pro90Leu) variant has been reported in the published literature in an individual with polyps (PMID: 34326862 (2021)), in individuals with head and neck squamous cell cancer (PMID: 28678401 (2017)), with ovarian cancer (PMID: 28881617 (2017)), with breast cancer (PMIDs: 36707629 (2023)), 36551643 (2022), and 33471991 (2021), see also LOVD (http://databases.lovd.nl/shared/genes/FANCM), and in reportedly healthy individuals (PMIDs: 36707629 (2023) and 28881617 (2017)). The frequency of this variant in the general population, 0.00067 (34/50818 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
not specified Uncertain:1
DNA sequence analysis of the FANCM gene demonstrated a sequence change, c.269C>T, in exon 1 that results in an amino acid change, p.Pro90Leu. This sequence change has been previously described in a patient with head and neck squamous cell carcinoma (PMID: 28678401) but no other details are available. It has been described in the gnomAD database with a population frequency of 0.062% in the non-Finnish European subpopulation (dbSNP rs142904668). The p.Pro90Leu change affects a moderately conserved amino acid residue located in a domain of the FANCM protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Pro90Leu substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Pro90Leu change remains unknown at this time. -
Fanconi anemia Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 90 of the FANCM protein (p.Pro90Leu). This variant is present in population databases (rs142904668, gnomAD 0.06%). This missense change has been observed in individual(s) with head and neck squamous cell carcinoma (PMID: 28678401). ClinVar contains an entry for this variant (Variation ID: 313189). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Spermatogenic failure 28;C4748170:Premature ovarian failure 15 Uncertain:1
- -
FANCM-related disorder Uncertain:1
The FANCM c.269C>T variant is predicted to result in the amino acid substitution p.Pro90Leu. This variant was reported in an individual with head and neck squamous cell carcinoma and in another individual with polyps, who also carried a POLE variant (Supplementary Table 3, Chandrasekharappa et al 2017. PubMed ID: 28678401; Table S4, Bhai. 2021. PubMed ID: 34326862), however it was also identified in a control population (Table S7, Dicks et al. 2017. PubMed ID: 28881617). This variant is reported in 0.062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-45605503-C-T) and is interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/313189/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at